Validation of the NTX Wireless Patient Monitoring System

Vanderbilt University Medical Center1,303 enrolled

Overview

* Reduction in time to detection of Clinically Significant events * Reduction of time to Intervention during Clinically Significant events * Reduction in the number of admissions to Intensive Care

1200 patients will have wireless monitors attached to their arm. They will be randomized to have their vital signs filtered through software that generates alerts, or software that does not generate alerts. Low and high limit alarms will be set according to published guidelines and adjusted at will by the response team. If appropriate the Vanderbilt University Medical Center Rapid Response team will be initiated per Institutional Policy

Study Type

OBSERVATIONAL

Enrollment

1,303

Conditions

Desaturation Bradycardia Tachycardia Hypertension Hypotension

Interventions

Rapid Response Team (NTX wireless monitoring system)OTHER

If the subject is experiencing a life threatening change in their vital signs, the Rapid Response Team will be initiated per VUMC protocol.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Ability to give written informed consent * Patients that are hospitalized for longer than 24 hours and are located on the 4th, 5th, or 6th floor of the Vanderbilt University Medical Center Round Wing * Patients must be ≥18 years of age Exclusion Criteria: * ICU patients * Female subjects who are pregnant * Patients \< 18 years of age * Patients that have a contradiction for continuous Blood Pressure monitoring

Locations (1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Outcomes

Primary Outcomes

To determine if the NTX wireless monitoring system in combination with a novel computer interface will provide early detection of potentially life threatening changes in patient's vital signs

Time frame: an interim analysis will be performed after 400 patients have been placed on the study, again after 800 have been places on the study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.